Results 71 to 80 of about 295,979 (212)

Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus [PDF]

open access: yes, 2016
Objective The objective of this study was to assess Modified Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and European Consensus Lupus Activity Measurement (ECLAM) disease activity correlation in addition to their respective ...
Corrente, J. E. [UNESP]   +5 more
core   +1 more source

Ovarian necrotizing vasculitis in a patient with lupus [PDF]

open access: yes, 2009
Ovarian vasculitis is a rare complication seen in the reproductive system and has been described in only one patient with lupus and a few patients with other rheumatic conditions (polyarteritis nodosa, giant cell arteritis, scleroderma). Three additional
SILVA, C. A. A.   +5 more
core   +1 more source

Circus Lupus, Super Genius promotional poster, 1992 [PDF]

open access: yes, 1992
Poster promoting an album, "Super Genius" by the Washington, D.C. punk band, Circus Lupus.
Dischord Records
core  

Methotrexate therapy in systemic lupus erythematosus [PDF]

open access: yes, 2001
There are 12 non-controlled and only two controlled studies using methotrexate (MTX) in a total of 207 SLE patients in the literature. the majority of these studies evaluated mainly cutaneous and/or articular involvement and attained good results.
Sato, E. I.
core   +1 more source

A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus

open access: yesClinical Proteomics, 2017
Subcellular microvesicles (MVs) have attracted increasing interest during the past decades. While initially considered as inert cellular debris, several important roles for MVs in physiological homeostasis, cancer, cardiovascular, and autoimmune diseases
Christoffer T. Nielsen   +4 more
doaj   +1 more source

Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis. [PDF]

open access: yes, 2009
The objective of this study was to evaluate the patterns of clinical manifestations and their mortality in a large cohort of Chinese patients with systemic lupus erythematosus.
Lau, CS   +5 more
core   +1 more source

A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases

open access: yesACR Open Rheumatology
Chimeric antigen receptor (CAR) T‐cell therapy, long transformative in oncology, is now rapidly emerging as a frontier in autoimmune rheumatic diseases, particularly systemic lupus erythematosus (SLE), driven by accumulating evidence of deep B‐cell ...
Roberto Caricchio   +11 more
doaj   +1 more source

Lupus vulgar, reporte de un caso [PDF]

open access: yes, 2018
Lupus vulgaris is one of the most common forms of cutaneous tuberculosis. It is a chronic and benign form that usually occurs in patients that had been previously sensitized to Mycobacterium tuberculosis and its diagnosis is based mainly in the clinical ...
Maldonado, Juliana; Pontificia Universidad Javeriana   +2 more
core  

Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus : a cross-sectional study [PDF]

open access: yes, 2017
Objective The objective of this study was to investigate the association of clinical and renal disease activity with circulating sphingolipids in patients with systemic lupus erythematosus.
Jakobsson, P-J   +14 more
core   +1 more source

BRWD1 orchestrates epigenetic landscape of late B lymphopoiesis

open access: yesNature Communications, 2018
B-cell development is tightly regulated by transcription programs that are coordinated by transcription factors (TF) and locus accessibility. Here the authors show that, in mice and humans, the epigenetic reader BRWD1 inhibits and promotes the ...
Malay Mandal   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy